×

Do you want to link to this External Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this Amgen Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN KOREA'S WEB SITE. Amgen Korea takes takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Kyprolis

KYPROLIS® Inj. 60mg, 30mg

  • Product Name (Korean) 키프롤리스주 60mg, 키프롤리스주 30mg
  • Product Name (English) Kyprolis®  Inj. 60mg, Kyprolis®  Inj. 30mg
  • Active Ingredient (Korean) 카르필조밉
  • Active Ingredient (English) carfilzomib
  • API content 60 mg/vial, 30 mg/vial
  • Excipients Betadex sulfobutyl ether sodium (SBECD), Anhydrous citric acid, Sodium hydroxide
  • Treatment Treatment of multiple myeloma.
  • Indications The combination therapy with lenalidomide and dexamethasone or with dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
  • KYPROLIS® Medication Guide